<- Go Home
CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Market Cap
$594.9M
Volume
242.9K
Cash and Equivalents
$153.4M
EBITDA
-$44.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$62.4M
Profit Margin
87.25%
52 Week High
$32.75
52 Week Low
$10.01
Dividend
N/A
Price / Book Value
3.27
Price / Earnings
-7.20
Price / Tangible Book Value
3.27
Enterprise Value
$434.0M
Enterprise Value / EBITDA
-10.10
Operating Income
-$45.5M
Return on Equity
41.39%
Return on Assets
N/A
Cash and Short Term Investments
$182.7M
Debt
$21.8M
Equity
$180.9M
Revenue
$71.5M
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium